Importantly, chronic P110 treatment in AD transgenic mice improved cognitive deficits and reduced amyloidβ pathology and oxidative stress.139 These results demonstrate that targeted DRP1-Fis1 inhibition can be neuroprotective and may translate to muscle aging contexts where excessive fission is detrimental. This evidence concerns the gene DNM1L and Alzheimer disease.